Abstract Library

#552 Outcomes After Liver Resection and Multidisciplinary Management of Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases

Introduction: Metastatic liver disease from neuroendocrine tumors (mNETs) has a significant impact on prognosis. Although complete surgical resection remains the only potentially curative therapy, a multimodal approach is becoming the standard by which it is managed.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Fehr A, Bhatia P, Kocha W, Reid R, Elliott J,

Keywords: liver metastases, liver resection, multimodality,

#530 Liver Transplantation for Metastatic Neuroendocrine Tumor: A Case Series and Proposed Selection Criteria

Introduction: Liver transplantation (LT) for neuroendocrine tumor (NET) metastases is associated with a high risk of tumor recurrence. Patient selection is the key to future success and its increased utilization.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Chan G, Kocha W, Reid R, Taqi A, Wall W,

Keywords: liver transplantation, neuroendocrine tumor, metastases,

#235 Robot-assisted Distal Pancreatectomy for Insulinoma. A Case Report

Introduction: A literature review on laparoscopic pancreatic resection was conducted with emphasis on its applicability and safety. The outcome of the procedures for pancreatic insulinoma is similar to open surgery.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Kriger A, Kochatkov A, Berelavichus S, Lebedeva A, Karelskaya N,

Keywords: robot-assisted procedures, distal pancreatectomy, insulinoma,

#74 Non-functioning pancreatic endocrine tumors: diagnostic criteria and surgical treatment

Introduction: Neuroendocrine tumors were considered rare tumors several years ago. Several reports published recently have observed increased incidence of NETs suggesting that NETs are more prevalent than previously reported. Non-functioning pancreatic endocrine tumors (NFPETs), better defined as non-hyperfunctioning, are characterized by the absence of clinical or biochemical evidence of hormone hypersecretion. From the clinical standpoint, NFPETs can be either occasionally encountered or manifest clinically similar pancreatic tumors. Since both NFPET treatment and prognosis significantly differ from that of ductal adenocarcinoma and other pancreatic malignant tumors, an accurate differential diagnosis is needed.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Kochatkov A, Kriger A, Karmazanovsky G, Fedorov A,

Keywords: nonfunctioning pancreatic endocrine tumors, diagnostic criteria, surgical treatment,

#61 Multiple tumors in patients with pancreatic neuroendocrine tumours: morphological and immunohistochemical characteristics

Introduction: Pancreatic islet cell tumors occur in 80% of patients with MEN 1. Tumors are often multicentric. They often produce multiple peptides and biogenic amines.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Gurevich L, Egorov A, Askenderova E, Kubyshkin V, Kochatkov A,

Keywords: pancreatic islet cell tumor, pancreatic neuroendocrine tumor, MEN 1 syndrome, neuroendocrine marker, hormone,